What's in Fundacion Nacional de Dermatologia's pipeline?

Fundacion Nacional de Dermatologia has 3 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Fundacion Nacional de Dermatologia's portfolio?

Top competitors by shared drug class: Bharat Serums and Vaccines Limited, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Dr. Falk Pharma GmbH, Drugs for Neglected Diseases.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fundacion-nacional-de-dermatologia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Fundacion Nacional de Dermatologia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fundacion Nacional de Dermatologia pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Group 3: Liposomal amphotericin B	Group 3: Liposomal amphotericin B	phase 3	Polyene antifungal	Ergosterol	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bharat Serums and Vaccines Limited · 1 shared drug class
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 1 shared drug class
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · 1 shared drug class
Dr. Falk Pharma GmbH · 1 shared drug class
Drugs for Neglected Diseases · 1 shared drug class
Federal University of Health Science of Porto Alegre · 1 shared drug class
Pfizer · 1 shared drug class
Poitiers University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundacion Nacional de Dermatologia:

Cite this brief

Drug Landscape (2026). Fundacion Nacional de Dermatologia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fundacion-nacional-de-dermatologia. Accessed 2026-05-18.